This study is intended to evaluate the efficacy and safety of lamotrigine as an
antidepressant augmentation agent in a sample of individuals with major depression and a
history of both prior non-response and prospective failure to respond to at least one
adequate trial of an antidepressant (for a total of two failed trials).
Phase:
N/A
Details
Lead Sponsor:
Louisiana State University Health Sciences Center in New Orleans